Published in Physiol Genomics on September 30, 2008
Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension (2010) 1.94
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev (2013) 1.60
MicroRNA: a new frontier in kidney and blood pressure research. Am J Physiol Renal Physiol (2009) 1.41
Novel role of fumarate metabolism in dahl-salt sensitive hypertension. Hypertension (2009) 1.25
Dynamic convergence and divergence of renal genomic and biological pathways in protection from Dahl salt-sensitive hypertension. Physiol Genomics (2009) 1.06
MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis. Physiol Genomics (2011) 1.02
Epigenomics of hypertension. Semin Nephrol (2013) 1.00
Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla. Hypertension (2010) 0.97
Increased proliferative cells in the medullary thick ascending limb of the loop of Henle in the Dahl salt-sensitive rat. Hypertension (2012) 0.92
Overexpression of HIF prolyl-hydoxylase-2 transgene in the renal medulla induced a salt sensitive hypertension. J Cell Mol Med (2012) 0.92
Hsd11b2 haploinsufficiency in mice causes salt sensitivity of blood pressure. Hypertension (2011) 0.90
Renal Tumor Necrosis Factor α Contributes to Hypertension in Dahl Salt-Sensitive Rats. Sci Rep (2016) 0.81
Silencing of hypoxia-inducible factor-1α gene attenuates chronic ischemic renal injury in two-kidney, one-clip rats. Am J Physiol Renal Physiol (2014) 0.80
Glucocorticoids and renal Na+ transport: implications for hypertension and salt sensitivity. J Physiol (2014) 0.80
Elevation of Fumarase Attenuates Hypertension and can Result from a Nonsynonymous Sequence Variation or Increased Expression Depending on Rat Strain. Physiol Genomics (2017) 0.75
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16
11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev (2004) 3.56
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science (1988) 2.93
Genetic analysis of inherited hypertension in the rat. Physiol Rev (2000) 2.78
The genetic dissection of essential hypertension. Nat Rev Genet (2006) 2.77
MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res (2008) 2.51
Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet (1987) 2.50
Whither RNAi? Nat Cell Biol (2003) 2.19
A genomic-systems biology map for cardiovascular function. Science (2001) 2.09
Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A (2004) 2.08
NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension (2006) 1.99
Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat. Hypertension (2001) 1.99
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest (2003) 1.95
Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation (2002) 1.94
11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev (1997) 1.91
The role of the kidney in hypertension. JAMA (1996) 1.80
Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol (2003) 1.52
Role of the renal medulla in volume and arterial pressure regulation. Am J Physiol (1997) 1.50
Consomic rat model systems for physiological genomics. Acta Physiol Scand (2004) 1.50
The renal medulla and hypertension. Hypertension (1995) 1.46
Dahl salt-susceptible and salt-resistant rats. A review. Hypertension (1983) 1.41
Primary role of renal homografts in setting chronic blood pressure levels in rats. Circ Res (1975) 1.34
Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res (2003) 1.32
Thiol-related genes in diabetic complications: a novel protective role for endogenous thioredoxin 2. Arterioscler Thromb Vasc Biol (2006) 1.22
Renal regional proteomes in young Dahl salt-sensitive rats. Hypertension (2008) 1.20
Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiol Genomics (2005) 1.20
Glucocorticoid response elements and 11 beta-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovasc Res (2008) 1.15
Insights into Dahl salt-sensitive hypertension revealed by temporal patterns of renal medullary gene expression. Physiol Genomics (2003) 1.14
Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol (1994) 1.14
Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension (1991) 1.12
Renal medullary genes in salt-sensitive hypertension: a chromosomal substitution and cDNA microarray study. Physiol Genomics (2002) 1.10
Abnormal renal hemodynamics and pressure-natriuresis relationship in Dahl salt-sensitive rats. Am J Physiol (1986) 1.09
Genetic and nongenetic determinants of salt sensitivity and blood pressure. Am J Clin Nutr (1997) 1.02
Renal intramedullary infusion of L-arginine prevents reduction of medullary blood flow and hypertension in Dahl salt-sensitive rats. Hypertension (1999) 1.00
Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis. Physiol Genomics (2007) 0.98
Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat. Endocrinology (2007) 0.95
High throughput gene expression profiling: a molecular approach to integrative physiology. J Physiol (2004) 0.93
The intrarenal localization of mineralocorticoid receptors and 11 beta-dehydrogenase: immunocytochemical studies. Endocrinology (1989) 0.91
Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians. Hypertension (2004) 0.91
Skeletal muscle arteriolar reactivity in SS.BN13 consomic rats and Dahl salt-sensitive rats. Hypertension (2003) 0.89
Sodium sensitivity in normotensive and borderline hypertensive humans. Am J Med Sci (1988) 0.88
Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats. Am J Physiol Renal Physiol (2007) 0.87
Immunohistochemical localization of 11-hydroxysteroid dehydrogenase in rat kidney with monoclonal antibody. Ren Physiol Biochem (1990) 0.83
Towards multifunctional synthetic vectors. Curr Gene Ther (2004) 0.83
Renal 11beta-hydroxysteroid dehydrogenase in genetically salt-sensitive hypertensive rats. Hypertension (1998) 0.80
Gene expression of 11 beta-hydroxysteroid dehydrogenase in the mesenteric arteries of genetically hypertensive rats. Hypertension (1994) 0.77
Regulation of the genes for 11beta-hydroxysteroid dehydrogenase type 1 and type 2 in the kidney of the Dahl rat. J Hypertens (1999) 0.77
11Beta-hydroxysteroid dehydrogenase in the Dahl rat. Am J Hypertens (1997) 0.76
Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology (2007) 3.85
A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab (2003) 3.25
Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology (2007) 3.08
Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation (2002) 2.93
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology (2003) 2.61
MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res (2008) 2.51
Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem (2003) 2.38
Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics (2013) 2.27
Increased expression of NAD(P)H oxidase subunit p67(phox) in the renal medulla contributes to excess oxidative stress and salt-sensitive hypertension. Cell Metab (2012) 2.18
Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney Int (2012) 2.12
The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics (2012) 2.08
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol (2010) 2.06
NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension (2006) 1.99
The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care (2006) 1.95
Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension (2010) 1.94
Simultaneous determination of 12 steroids by isotope dilution liquid chromatography-photospray ionization tandem mass spectrometry. Clin Chim Acta (2006) 1.89
Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab (2003) 1.77
Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium. Proc Natl Acad Sci U S A (2013) 1.70
Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D? Clin Chem (2008) 1.69
Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab (2007) 1.60
Association of adrenal steroids with hypertension and the metabolic syndrome in blacks. Hypertension (2006) 1.57
High perfusion pressure accelerates renal injury in salt-sensitive hypertension. J Am Soc Nephrol (2008) 1.50
Glutathione: a marker and antioxidant for aging. J Lab Clin Med (2002) 1.44
Cortisol metabolism in the Bolivian squirrel monkey (Saimiri boliviensis boliviensis). Comp Med (2006) 1.42
Xenon Protects Against Septic Acute Kidney Injury via miR-21 Target Signaling Pathway. Crit Care Med (2015) 1.42
MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382. Nucleic Acids Res (2010) 1.42
Vitamin D (25OHD) Serum Seasonality in the United States. PLoS One (2013) 1.41
LC-MS/MS in the Clinical Laboratory - Where to From Here? Clin Biochem Rev (2011) 1.36
Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing. Retina (2006) 1.30
Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension (2012) 1.28
Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants. Clin Chem (2009) 1.28
Effect of sodium delivery on superoxide and nitric oxide in the medullary thick ascending limb. Am J Physiol Renal Physiol (2006) 1.26
Novel role of fumarate metabolism in dahl-salt sensitive hypertension. Hypertension (2009) 1.25
Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. J Clin Endocrinol Metab (2012) 1.23
17alpha-estradiol: a brain-active estrogen? Endocrinology (2005) 1.22
Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure. Am J Physiol Renal Physiol (2005) 1.21
Renal regional proteomes in young Dahl salt-sensitive rats. Hypertension (2008) 1.20
Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiol Genomics (2005) 1.20
Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway. Diabetes (2004) 1.16
Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology (2007) 1.15
Glucocorticoid response elements and 11 beta-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovasc Res (2008) 1.15
Maternal vitamin D supplementation to improve the vitamin D status of breast-fed infants: a randomized controlled trial. Mayo Clin Proc (2013) 1.14
Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes. Retina (2004) 1.13
Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years. J Clin Endocrinol Metab (2007) 1.11
Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem (2002) 1.11
Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases. J Clin Endocrinol Metab (2007) 1.11
Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response. Physiol Genomics (2004) 1.08
Dynamic convergence and divergence of renal genomic and biological pathways in protection from Dahl salt-sensitive hypertension. Physiol Genomics (2009) 1.06
Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients. Pediatrics (2004) 1.06
Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans. J Clin Endocrinol Metab (2005) 1.05
Increasing liquid chromatography-tandem mass spectrometry throughput by mass tagging: a sample-multiplexed high-throughput assay for 25-hydroxyvitamin D2 and D3. Clin Chem (2011) 1.04
Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J Clin Endocrinol Metab (2010) 1.04
miR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-α activation. Am J Physiol Renal Physiol (2013) 1.03
Comparison of metabolism of vitamins D2 and D3 in children with nutritional rickets. J Bone Miner Res (2010) 1.02
MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis. Physiol Genomics (2011) 1.02
Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial. J Clin Endocrinol Metab (2014) 1.01
Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays. Clin Chem (2005) 1.01
MicroRNAs contribute to the maintenance of cell-type-specific physiological characteristics: miR-192 targets Na+/K+-ATPase β1. Nucleic Acids Res (2012) 1.01
Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids (2009) 1.00
miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice. Anesthesiology (2013) 0.99
Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry. Clin Chem (2009) 0.99
Elevated fibroblast growth factor 23 in women with malignant ovarian tumors. Mayo Clin Proc (2005) 0.99
Determination of serum and plasma sclerostin concentrations by enzyme-linked immunoassays. J Clin Endocrinol Metab (2011) 0.99
Mitochondrial proteomic analysis reveals deficiencies in oxygen utilization in medullary thick ascending limb of Henle in the Dahl salt-sensitive rat. Physiol Genomics (2012) 0.99
Rapid measurement of estrogens and their metabolites in human serum by liquid chromatography-tandem mass spectrometry without derivatization. Clin Biochem (2008) 0.99
Substitution of 3'-phosphate cap with a carbon-based blocker reduces the possibility of fluorescence resonance energy transfer probe failure in real-time PCR assays. Clin Chem (2004) 0.99
Pharmacokinetic study of vitreous and serum concentrations of triamcinolone acetonide after posterior sub-tenon's injection. Am J Ophthalmol (2012) 0.98
Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis. Physiol Genomics (2007) 0.98
Increasing incidence of nutritional rickets: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc (2013) 0.96
Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity. Diabetes (2006) 0.96
Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism. Mayo Clin Proc (2004) 0.95
Narrowing a region on rat chromosome 13 that protects against hypertension in Dahl SS-13BN congenic strains. Am J Physiol Heart Circ Physiol (2011) 0.95
Base-resolution maps of 5-methylcytosine and 5-hydroxymethylcytosine in Dahl S rats: effect of salt and genomic sequence. Hypertension (2014) 0.94
Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids. Clin Chem (2004) 0.93
Measurement of plasma free metanephrine and normetanephrine by liquid chromatography-tandem mass spectrometry for diagnosis of pheochromocytoma. Clin Chem (2004) 0.93
Increased proliferative cells in the medullary thick ascending limb of the loop of Henle in the Dahl salt-sensitive rat. Hypertension (2012) 0.92
Characteristics of microRNAs enriched in specific cell types and primary tissue types in solid organs. Physiol Genomics (2013) 0.91
Circulating free nitrotyrosine in obstructive sleep apnea. Am J Physiol Regul Integr Comp Physiol (2004) 0.91
A novel amiloride-sensitive h+ transport pathway mediates enhanced superoxide production in thick ascending limb of salt-sensitive rats, not na+/h+ exchange. Hypertension (2009) 0.90
RNASeq-derived transcriptome comparisons reveal neuromodulatory deficiency in the CO2 insensitive brown Norway rat. J Physiol (2014) 0.90
Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology (2007) 0.90
Validation of liquid chromatography-tandem mass spectrometry method for analysis of urinary conjugated metanephrine and normetanephrine for screening of pheochromocytoma. Clin Chem (2002) 0.89
Targeting the endothelial progenitor cell surface proteome to identify novel mechanisms that mediate angiogenic efficacy in a rodent model of vascular disease. Physiol Genomics (2013) 0.88
Renal interstitial corticosterone and 11-dehydrocorticosterone in conscious rats. Am J Physiol Renal Physiol (2007) 0.87
Research resource: whole transcriptome RNA sequencing detects multiple 1α,25-dihydroxyvitamin D(3)-sensitive metabolic pathways in developing zebrafish. Mol Endocrinol (2012) 0.86
Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr Pract (2012) 0.86
Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina (2006) 0.85
Marital status and variability in cortisol excretion in postmenopausal women. Biol Psychol (2007) 0.85
Translational study of microRNAs and its application in kidney disease and hypertension research. Clin Sci (Lond) (2012) 0.85